Welcome to our dedicated page for ZK International Group Co. Ordinary Share news (Ticker: $ZKIN), a resource for investors and traders seeking the latest updates and insights on ZK International Group Co. Ordinary Share stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect ZK International Group Co. Ordinary Share's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of ZK International Group Co. Ordinary Share's position in the market.
ZK International Group Co., announced the successful closing of a $5 million financing, with $1.5 million investment at a 165% premium. The investment reinforces CF Opportunity Fund's confidence in ZK's growth potential. The Company issued 3,154,885 ordinary shares at $1.59 per share, utilizing the net proceeds for working capital and general corporate purposes.
ZK International Group Co., has been granted an exception by Nasdaq Staff regarding its Form 20-F filing for the period ended September 30, 2023. Following a review, Nasdaq Staff has determined to grant an exception to enable the Company to regain compliance with the Rule, requiring the Company to file the Form 20-F by June 7, 2024. Failure to meet these terms may result in potential delisting of its securities.